Atnaujinkite slapukų nuostatas

El. knyga: Conquest of Invisible Enemies: A Human History of Antiviral Drugs

(Vice President, Discovery Chemistry, ChemPartner)
  • Formatas: EPUB+DRM
  • Išleidimo metai: 18-Nov-2022
  • Leidėjas: Oxford University Press Inc
  • Kalba: eng
  • ISBN-13: 9780197609873
  • Formatas: EPUB+DRM
  • Išleidimo metai: 18-Nov-2022
  • Leidėjas: Oxford University Press Inc
  • Kalba: eng
  • ISBN-13: 9780197609873

DRM apribojimai

  • Kopijuoti:

    neleidžiama

  • Spausdinti:

    neleidžiama

  • El. knygos naudojimas:

    Skaitmeninių teisių valdymas (DRM)
    Leidykla pateikė šią knygą šifruota forma, o tai reiškia, kad norint ją atrakinti ir perskaityti reikia įdiegti nemokamą programinę įrangą. Norint skaityti šią el. knygą, turite susikurti Adobe ID . Daugiau informacijos  čia. El. knygą galima atsisiųsti į 6 įrenginius (vienas vartotojas su tuo pačiu Adobe ID).

    Reikalinga programinė įranga
    Norint skaityti šią el. knygą mobiliajame įrenginyje (telefone ar planšetiniame kompiuteryje), turite įdiegti šią nemokamą programėlę: PocketBook Reader (iOS / Android)

    Norint skaityti šią el. knygą asmeniniame arba „Mac“ kompiuteryje, Jums reikalinga  Adobe Digital Editions “ (tai nemokama programa, specialiai sukurta el. knygoms. Tai nėra tas pats, kas „Adobe Reader“, kurią tikriausiai jau turite savo kompiuteryje.)

    Negalite skaityti šios el. knygos naudodami „Amazon Kindle“.

"COVID-19 reminds us how acutely the virus can impact humanity. In fact, viruses existed long before the emergence of homo sapiens. In this book on the history of antiviral drug discovery, the human aspects are highlighted. In Chapter 1, the author regales us with several episodes where history was shaped by viruses causing smallpox, yellow fever, etc. The fascinating history of the first discovery of virus, tobacco mosaic virus, was also recounted. Chapters 2-5 covered four classes of viruses such as HIV, hepatitis viruses, influenza viruses and coronaviruses. Each chapter begins how the virus was discovered, followed by vaccine development, and then focuses on the discovery of small molecule antiviral drugs. For chemistry aficionados, the end of the book is replete with abundant of bibliography for further understanding of the minutia of the stories, followed by molecular structures of the antiviral drugs. This book is of interest to anyone who wants to know the science behind virus, vaccines and antiviral drugs. It is especially useful for healthcare professionals who are interested in knowing how viruses, vaccines and antiviral drugs are discovered"--

It's time to examine the human history of viruses, vaccines, and antiviral drugs...

Public response to the COVID-19 pandemic has demonstrated that misinformation about viruses is widespread. Vaccine skepticism is rampant, and many people have been quick to accept bogus claims unsupported by science. In his latest book, Jie Jack Li sets the record straight by revealing the science and history behind antiviral drugs.

Conquest of Invisible Enemies: A Human History of Antiviral Drugs guides readers through the history of viruses, vaccinations, and treatments. Readers learn about the discovery of viruses and diseases, such as HIV/AIDS, hepatitis, influenza, and SARS-CoV-2 (COVID-19). The first chapter takes an expansive look at how viruses have shaped human history. Subsequent chapters narrow in on specific viruses, diseases, and drug treatments. For example, chapter four, on influenza, looks at the 1918 Spanish flu pandemic, the history of vaccination efforts, and influenza drugs and vaccines today. Chapter five, on coronaviruses, considers drug treatments for SARS, MERS, and SARS-CoV-2. It also discusses the development of COVID-19 vaccines and drugs.

Conquest of Invisible Enemies: A Human History of Antiviral Drugs focuses on the human drama behind drug discovery. Written in an engaging and accessible style, Li's timely book dispels common misconceptions about viruses and treatments and places the COVID-19 pandemic in historical context.

Recenzijos

After summarising current vaccine research and the hunt for a universal vaccine, Li provides an overview of an tiviral influenza treatments from M2 ion channel inhibitors to neuraminidase inhibitors such as Tamiflu. * Claas Kirchhelle, Metascience *


Preface

Chapter
1. Virus Shaping History and Discovery of Virus

1.1 Virus shaping history
1.1.1 Tulipomania: bubbles of bulbs
1.1.2 The fall of old Mexico and Peru
1.1.3 Succession of thrones
1.1.4 The Louisiana Purchase
1.2 Discovery of virus
1.2.1 The gem theory
1.2.2 Discovery of virus
1.2.3 Cancer-causing viruses
1.2.4 Discovery of retrovirus

Chapter
2. HIV/AIDS Drugs, Transforming a Death Sentence to a Chronic Disease

2.1 Discovery of the virus
2.1.1 A death sentence
2.1.2 Discovery of HIV and the great scientific controversy
2.1.3 The Nobel Prize
2.2 The first ray of hope
2.2.1 Nucleoside antiviral drugs
2.2.2 Non-nucleoside reverse transcriptase inhibitors
2.3 HIV protease inhibitors
2.3.1 HIV protease
2.3.2 First-generation HIV protease inhibitors
2.3.3 Second-generation HIV protease inhibitors
2.4 HIV integrase inhibitors
2.5 HIV Entry Inhibitors
2.5.1 HIV fusion inhibitors
2.5.2 CCR5 inhibitors
2.6 Triumph of modern medicine

Chapter
3. Hepatitis Drugs

3.1 Hepatitis A virus
3.1.1 Discovery of hepatitis A virus
3.1.2 Hepatitis A vaccines
3.2 Hepatitis B virus
3.2.1 Discovery of hepatitis B virus
3.2.2 Hepatitis B vaccines
3.2.3 Hepatitis B drugs
3.3 Hepatitis C virus
3.3.1 Discovery of Hepatitis C virus
3.3.2 Hepatitis C virus NS3/4A protease inhibitors
3.3.3 Hepatitis C virus NS5A replication complex inhibitors
3.3.4 Hepatitis C virus NS5B polymerase inhibitors
3.4 Triumph of modern medicines

Chapter
4. Influenza: A Perennial Killer

4.1 Influenza, a perennial killer
4.2 A virus that changed the world: the 1918 Spanish flu pandemic
4.3 Discovery of the influenza virus
4.4 Influenza vaccines
4.4.1 History of vaccination
4.4.2 History of influenza vaccines
4.4.3 Influenza vaccines today
4.5 Influenza drugs
4.5.1 M2 inhibitors
4.5.2 Influenza virus neuraminidase inhibitors
4.5.3 Cap-dependent endonuclease https://en.wikipedia.org/wiki/Ribonuclease inhibitor

Chapter
5. Coronaviruses

5.1 Coronavirus Drugs
5.1.1. SARS
5.1.2. MARS
5.1.3. SARS-CoV-2
5.2 COVID-19 Vaccines
5.2.1. Pfizer/Biotech's mRNA vaccine
5.2.2. Johnson & Johnson's viral vector vaccine
5.3 COVID-19 Drugs
5.3.1. Remdesivir (Veklury)
5.3.2. Dexamethasone

Chapter
6. Closing Remarks


Bibliography
Chemical Structures of Antiviral Drugs
Jie Jack Li is the CSO of GenHouse Bio. Previously, he was VP of Discovery Chemistry at ChemPartner, an Associate Professor of Chemistry at the University of San Francisco, and a Medicinal Chemist at Pfizer and Bristol-Myers Squibb. He has authored or edited over 30 books, including Blockbuster Drugs (Oxford University Press, 2014), which won the 2015 Alpha Sigma Nu Science Book Award.